Frontiers | Phosphodiesterase-4 Inhibitors for the Treatment of Inflammatory Diseases
Frontiers | Inhaled Phosphodiesterase 4 (PDE4) Inhibitors for Inflammatory Respiratory Diseases
Advances in the Development of Phosphodiesterase-4 Inhibitors | Journal of Medicinal Chemistry
An Overview of PDE4 Inhibitors in Clinical Trials | Encyclopedia MDPI
Phosphodiesterase 4 inhibitors | Semantic Scholar
Phosphodiesterase inhibitor - Wikipedia
Targeting phosphodiesterase 4 as a potential therapeutic strategy for enhancing neuroplasticity following ischemic stroke
Potent PDE4 inhibitor activates AMPK and Sirt1 to induce mitochondrial biogenesis | PLOS ONE
Phosphodiesterase-4 (PDE4) inhibitors have the potential to suppress... | Download Scientific Diagram
Schematic representation of how Phosphodiesterase 4 (PDE4) inhibitors,... | Download Scientific Diagram
Molecules | Free Full-Text | An Overview of PDE4 Inhibitors in Clinical Trials: 2010 to Early 2022
PDE4 as Therapeutic Targets in Different Diseases | Encyclopedia MDPI
Frontiers | Phosphodiesterase-4 Inhibitors for the Treatment of Inflammatory Diseases
Selective Phosphodiesterase Inhibitors: A New Therapeutic Option in Inflammation and Autoimmunity | Reumatología Clínica
Phosphodiesterase Inhibitors: What Are They, How Do They Work, What Are They Used For, and More | Osmosis
PDE4 inhibition: a novel approach for the treatment of inflammatory bowel disease: Trends in Pharmacological Sciences
Inhibition of PDE4B suppresses inflammation by increasing expression of the deubiquitinase CYLD | Nature Communications
GSK356278 is a Selective and Orally Bioavailable PDE4 Inhibitor - Immune System Research
Otezla Mechanism of Action (MOA) — PDE4 Inhibitor | Otezla® (apremilast) Healthcare Professional Site
Inhibition of PDE4 protects neurons against oxygen-glucose deprivation-induced endoplasmic reticulum stress through activation of the Nrf-2/HO-1 pathway - ScienceDirect
Phosphodiesterase-4 inhibitor - Wikipedia
PDE4 subtypes in cancer | Oncogene
The effect and associated mechanism of action of phosphodiesterase 4 (PDE4) inhibitor on CD4+ lymphocyte proliferation - Kim - 2021 - Clinical and Experimental Pharmacology and Physiology - Wiley Online Library
PDE4 inhibitors in COPDFa more selective approach to treatment
